MX388148B - Composicion de absorcion percutanea. - Google Patents

Composicion de absorcion percutanea.

Info

Publication number
MX388148B
MX388148B MX2018002015A MX2018002015A MX388148B MX 388148 B MX388148 B MX 388148B MX 2018002015 A MX2018002015 A MX 2018002015A MX 2018002015 A MX2018002015 A MX 2018002015A MX 388148 B MX388148 B MX 388148B
Authority
MX
Mexico
Prior art keywords
basic
sorbic acid
basic drug
preferred
percutaneous absorption
Prior art date
Application number
MX2018002015A
Other languages
English (en)
Other versions
MX2018002015A (es
Inventor
Hidetoshi Hamamoto
Naoya AKAZAWA
Yasushi Miwa
Original Assignee
Medrx Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medrx Co Ltd filed Critical Medrx Co Ltd
Publication of MX2018002015A publication Critical patent/MX2018002015A/es
Publication of MX388148B publication Critical patent/MX388148B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición de absorción percutánea que tiene una permeabilidad en la piel mejorada de un medicamento básico y un agente para promover la capacidad de absorción transdérmico de un medicamento básico. El objetivo se puede lograr por el uso de una composición de absorción percutánea que comprende un medicamento básico o una sal del mismo y ácido sórbico y/o su sal de metal. Preferiblemente, la composición de la presente invención puede además comprender un compuesto básico orgánico y/o un componente básico inorgánico.
MX2018002015A 2015-08-29 2016-08-29 Composicion de absorcion percutanea. MX388148B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP2015/074553 WO2017037813A1 (ja) 2015-08-29 2015-08-29 塩基性薬物とソルビン酸とを含有する経皮吸収組成物
PCT/JP2016/075203 WO2017038767A1 (ja) 2015-08-29 2016-08-29 経皮吸収組成物

Publications (2)

Publication Number Publication Date
MX2018002015A MX2018002015A (es) 2018-06-19
MX388148B true MX388148B (es) 2025-03-19

Family

ID=58187853

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018002015A MX388148B (es) 2015-08-29 2016-08-29 Composicion de absorcion percutanea.

Country Status (15)

Country Link
EP (1) EP3342423B1 (es)
JP (2) JP6259117B2 (es)
KR (1) KR20180039622A (es)
CN (1) CN107427509B (es)
BR (1) BR112018001387B8 (es)
CO (1) CO2018001831A2 (es)
ES (1) ES2864017T3 (es)
MX (1) MX388148B (es)
MY (1) MY189987A (es)
PH (1) PH12018500271A1 (es)
RU (1) RU2702356C2 (es)
SG (1) SG11201800043UA (es)
UA (1) UA123212C2 (es)
WO (2) WO2017037813A1 (es)
ZA (1) ZA201800296B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019151423A1 (ja) * 2018-01-31 2019-08-08 株式会社 メドレックス チザニジン治療システム
TWI772807B (zh) * 2019-05-27 2022-08-01 日商救急藥品工業股份有限公司 外用製劑
WO2023031103A1 (en) * 2021-08-30 2023-03-09 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the transdermal administration of guanfacine comprising guanfacine and a mono-carboxylic acid
CN118103036A (zh) * 2021-10-15 2024-05-28 Lts罗曼治疗系统股份公司 用于透皮施用替扎尼定的透皮治疗系统
CN116370439A (zh) * 2022-04-01 2023-07-04 江苏山信药业有限公司 一种伐尼克兰透皮贴剂及其制备方法和其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61172830A (ja) * 1985-01-26 1986-08-04 Showa Denko Kk 皮膚外用剤組成物
US20040142024A1 (en) * 1999-07-27 2004-07-22 Hisamitsu Pharmaceutical Co., Inc. Patch formulation for external use
DK1201232T3 (da) * 1999-07-27 2007-08-13 Hisamitsu Pharmaceutical Co Plastre til ydre anvendelse
DK1729746T3 (da) * 2004-03-19 2010-03-08 Mcneil Ab Anordning til transdermal administration af nikotin
JP4807974B2 (ja) * 2005-06-30 2011-11-02 帝國製薬株式会社 経皮吸収促進組成物
CN101032474B (zh) * 2006-03-06 2011-02-16 重庆医药工业研究院有限责任公司 一种治疗或预防神经系统疾病的雷沙吉兰透皮贴片及其制备方法
CN101143127A (zh) * 2007-10-25 2008-03-19 复旦大学 一种酚妥拉明外用制剂及其制备方法
JP5333972B2 (ja) * 2007-11-22 2013-11-06 株式会社 メドレックス 脂肪酸系イオン液体を有効成分とする外用剤組成物
ES2648197T3 (es) * 2008-02-27 2017-12-29 Hisamitsu Pharmaceutical Co., Inc. Parche medicado
JP2012158521A (ja) * 2009-04-17 2012-08-23 Kureha Corp 外用剤
JP5780961B2 (ja) * 2009-09-07 2015-09-16 ニプロパッチ株式会社 経皮吸収型製剤
CN102858321A (zh) * 2010-06-18 2013-01-02 莫茨药物股份两合公司 用于局部使用1-氨基-烷基环己烷衍生物的凝胶制剂
CN110693859A (zh) * 2012-06-20 2020-01-17 美德阿利克斯株式会社 通过掺混药物、有机溶剂、亲脂性基质和粉末获得的粘附制剂组合物

Also Published As

Publication number Publication date
MY189987A (en) 2022-03-22
EP3342423A4 (en) 2018-07-25
JPWO2017038767A1 (ja) 2017-09-07
ES2864017T3 (es) 2021-10-13
CN107427509A (zh) 2017-12-01
ZA201800296B (en) 2019-04-24
EP3342423B1 (en) 2021-03-10
PH12018500271A1 (en) 2018-08-13
RU2702356C2 (ru) 2019-10-08
WO2017038767A1 (ja) 2017-03-09
RU2018110617A (ru) 2019-09-30
JP6259117B2 (ja) 2018-01-10
BR112018001387A2 (pt) 2018-09-11
MX2018002015A (es) 2018-06-19
EP3342423A1 (en) 2018-07-04
BR112018001387B8 (pt) 2024-03-05
RU2018110617A3 (es) 2019-09-30
CO2018001831A2 (es) 2018-05-21
SG11201800043UA (en) 2018-02-27
UA123212C2 (uk) 2021-03-03
WO2017037813A1 (ja) 2017-03-09
KR20180039622A (ko) 2018-04-18
CN107427509B (zh) 2021-06-15
BR112018001387B1 (pt) 2023-09-05
JP2017149782A (ja) 2017-08-31

Similar Documents

Publication Publication Date Title
PH12018500271A1 (en) A percutaneous absorption composition
JOP20200011A1 (ar) مركبات وتركيبات لمعالجة حالات مرضية مرتبطة بنشاط nlrp
CY1120635T1 (el) Βενζαμιδια αμινοετεροαρυλιου ως αναστολεις κινασης
BR112018016433A2 (pt) inibidores de heteroarila de pad4
EA201690287A1 (ru) 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом
BR112018005194A2 (pt) processo de composto antifúngico
MX2020010344A (es) Mezcla fertilizante que contiene inhibidor de la nitrificacion.
MX373678B (es) Composición farmacéutica de clorhidrato de s-cetamina.
MX373330B (es) Composiciones y métodos que comprenden bupropion o compuestos relacionados y dextrometorfano.
BR112015029495A2 (pt) compostos heterocíclicos como inibidores da via de sinalização hedgehog
BR112015028173A2 (pt) inibidores de acc e usos dos mesmos
EA201691156A1 (ru) Пирролидиноновые гербициды
BR112015024770B8 (pt) formulação biocida e método para tratamento de água
BR112015026297A2 (pt) terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer
BR112018005200A2 (pt) liberação de nanopartículas de fármaco e métodos de uso dos mesmos
EA201790070A1 (ru) Бифениламиды, содержащие модифицированные простые эфирные группы, в качестве ингибиторов hsp90 и стимуляторов hsp70
MX363457B (es) Compuestos de sulfonamida heterociclica sustituida utiles como moduladores del canal del receptor de potencial transitorio a1 (trpa1).
EA201891409A1 (ru) Бензамидные соединения и их применение в качестве гербицидов
BR112018008659A2 (pt) sililfenoxi-heterociclos trissubstituídos e análogos
EP3398947A4 (en) NITROGENIC CONDENSED HETEROCYCLIC COMPOUND, AND MANUFACTURING METHOD, INTERMEDIATE PRODUCTS, COMPOSITION, AND APPLICATION THEREOF
MX383254B (es) Combinacion que comprende un glucocorticoide y edo-s101.
PH12016502130B1 (en) Novel pyrrolopyrimidine compound or salt thereof, pharmaceutical composition containing same, especially agent for prevention and/or treatment of tumors etc based on nae inhibitory effect
EP3586848A4 (en) PHARMACEUTICAL COMPOSITION INCLUDING A COMPOUND SUITABLE TO CROSS THE HEMATOENCEPHALIC BARRIER AS AN ACTIVE PRINCIPLE TO PREVENT OR TREAT BRAIN CANCER
BR112015020222A2 (pt) compostos de azetidiniloxifenilpirrolidina
BR112017004991A2 (pt) compostos antimicrobianos de imidazólio